Supplemental Table S1 from FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

crossref(2023)

引用 0|浏览4
暂无评分
摘要

Supplemental Table S1: Grouped Terms for Adverse Reactions on Study 301

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要